According to the international consensus guidelines [2,3], breast cancer can be classified into four molecular subtypes defined by histological analysis and immunohistochemical analysis of progesterone receptor (PR), estrogen receptor (ER), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast carcinoma.